
CERT
Certara Inc.
Company Overview
| Mkt Cap | $892.35M | Price | $6.14 |
| Volume | 2.78M | Change | -1.60% |
| P/E Ratio | -74.0 | Open | $6.20 |
| Revenue | $385.1M | Prev Close | $6.24 |
| Net Income | $-12.1M | 52W Range | $5.19 - $15.38 |
| Div Yield | N/A | Target | $8.82 |
| Overall | 51 | Value | 60 |
| Quality | 60 | Technical | 33 |
No chart data available
About Certara Inc.
Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. The company also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix Hosted, which offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration, which supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform for drug discovery teams and their external collaborators; Certara D360 software, a scientific informatics system for small molecule and biologics discovery research; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and assembles regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.
Latest News
Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX) and Certara (CERT)
Cerrado Gold Posts Record 2025 EBITDA as Minera Don Nicolas Ramps Up Underground Output
Certara Announces Upcoming Board and Audit Committee Change
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CERT | $6.14 | -1.6% | 2.78M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |